CLINICAL RESEARCH: HYPERTENSION
Blood Pressure Response Under Chronic Antihypertensive Drug TherapyThe Role of Aortic Stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) Study
Athanase Protogerou, MD*,
Jacques Blacher, MD, PhD ,
George S. Stergiou, MD*,
Apostolos Achimastos, MD* and
Michel E. Safar, MD ,*
* Hypertension Center, Third Department of Medicine, Sotiria Hospital, University of Athens, Athens, Greece
Paris-Descartes University, Faculty of Medicine, Hôtel-Dieu Hospital, AP-HP, Diagnosis Center, Paris, France
Manuscript received February 11, 2008;
revised manuscript received September 4, 2008,
accepted September 8, 2008.
* Reprint requests and correspondence: Prof. Michel Safar, Diagnosis Center, Hôpital Hôtel-Dieu, 1, place du Parvis Notre-Dame, 75181 Paris Cedex 04, France (Email: michel.safar{at}htd.aphp.fr).
Objectives: We sought to evaluate the role of arterial stiffness on blood pressure (BP) response to drug treatment.
Background: Increased arterial stiffness (pulse wave velocity [PWV]) is associated with increased systolic blood pressure (SBP). Antihypertensive drug therapy achieves better control of diastolic blood pressure (DBP) than SBP does, implying that increased PWV might be a predictor of the SBP response to treatment.
Methods: The REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study is a randomized, double-blind trial comparing atenolol versus perindopril/indapamide; 375 patients with hypertension, with BP and PWV measurements at baseline and after 12 months of treatment, were divided into 3 tertiles according to baseline PWV and included in a post-hoc analysis.
Results: After 12 months of treatment, BP differed significantly between PWV tertiles (the third having the lowest response, p < 0.05). Factors related to smaller BP decline were low baseline BP, high baseline PWV, need for a double dose of treatment, use of atenolol (only for SBP response), and age (only for DBP). Although DBP control did not differ in the PWV tertiles, SBP control was significantly associated with PWV level (p = 0.001) as well as with the use of perindopril/indapamide (p < 0.001). The predictive value of PWV on BP response was independent of age, sex, mean BP, and cardiovascular risk factors.
Conclusions: Baseline PWV is a significant predictor of BP response to antihypertensive treatment, independent from age, the need for increasing drug dosage, and the presence of cardiovascular risk factors. Achievement of SBP control appears to be influenced by aortic stiffness as well as by angiotensin-converting enzyme inhibition.
Key Words: arterial stiffness pulse wave velocity antihypertensive therapy
|
Abbreviations and Acronyms
| | ACEI = angiotensin-converting enzyme inhibitor | | BMI = body mass index | | BP = blood pressure | | CF = carotid-femoral | | CV = cardiovascular | | DBP = diastolic blood pressure | | MAP = mean arterial pressure | | Per/Ind = perindopril/indapamide | | PWV = pulse wave velocity | | SBP = systolic blood pressure |
|
Related Articles
-
The Aorta and Resistant Hypertension
- Bryan Williams
J. Am. Coll. Cardiol. 2009 53: 452-454.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. E. Safar, A. Protogerou, and J. Blacher
Central Blood Pressure Under Angiotensin and Calcium Channel Blockade
Hypertension,
October 1, 2009;
54(4):
704 - 706.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Mackenzie, C. M. McEniery, Z. Dhakam, M. J. Brown, J. R. Cockcroft, and I. B. Wilkinson
Comparison of the Effects of Antihypertensive Agents on Central Blood Pressure and Arterial Stiffness in Isolated Systolic Hypertension
Hypertension,
August 1, 2009;
54(2):
409 - 413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Williams
The aorta and resistant hypertension.
J. Am. Coll. Cardiol.,
February 3, 2009;
53(5):
452 - 454.
[Full Text]
[PDF]
|
 |
|
|